Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Ellis

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot TrialZachary T Yoneda, Matthew O'Neill, Diane M Crawford, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2021
Safety and feasibility of peri-device leakage closure after LAAO: an international, multicentre collaborative studyKerstin Piayda, Kolja Sievert, Domenico G Della Rocca, et al.
Journal of the American Heart Association|March 12, 2024
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac RemodelingMajd A El-Harasis, Joseph A Quintana, J Roberto Martinez-Parachini, et al.
JACC. Clinical Electrophysiology|October 25, 2024
Clinical Characteristics and Outcomes in Patients With Atrial Fibrillation and Pathogenic TTN VariantsZain M Virk, Majd A El-Harasis, Zachary T Yoneda, et al.
JACC. Clinical Electrophysiology|September 7, 2024
Ablation for Atrial Fibrillation in Patients With Rare Pathogenic Variants in Cardiomyopathy and Arrhythmia GenesMajd A El-Harasis, Zachary T Yoneda, Katherine C Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
The Therapeutic Impact of Genetic Evaluation in an Atrial Fibrillation Precision Medicine ClinicJ Lukas Laws, Mahsima Shabani, Hollie L Williams, et al.
European Heart Journal|October 30, 2025
Genetic evaluation of early-onset atrial fibrillation: impact on patient managementJ Lukas Laws, Mahsima Shabani, Hollie L Williams, et al.
JACC. Cardiovascular Interventions|November 29, 2023
Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and OutcomesJules Mesnier, Trevor Simard, Richard G Jung, et al.
Journal of the American College of Cardiology|July 23, 2021
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage OcclusionTrevor Simard, Richard G Jung, Kyle Lehenbauer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2024
Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomesSophie Eppinger, Kerstin Piayda, Roberto Galea, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot TrialZachary T Yoneda, Matthew O'Neill, Diane M Crawford, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2021
Safety and feasibility of peri-device leakage closure after LAAO: an international, multicentre collaborative studyKerstin Piayda, Kolja Sievert, Domenico G Della Rocca, et al.
Journal of the American Heart Association|March 12, 2024
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac RemodelingMajd A El-Harasis, Joseph A Quintana, J Roberto Martinez-Parachini, et al.
JACC. Clinical Electrophysiology|October 25, 2024
Clinical Characteristics and Outcomes in Patients With Atrial Fibrillation and Pathogenic TTN VariantsZain M Virk, Majd A El-Harasis, Zachary T Yoneda, et al.
JACC. Clinical Electrophysiology|September 7, 2024
Ablation for Atrial Fibrillation in Patients With Rare Pathogenic Variants in Cardiomyopathy and Arrhythmia GenesMajd A El-Harasis, Zachary T Yoneda, Katherine C Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
The Therapeutic Impact of Genetic Evaluation in an Atrial Fibrillation Precision Medicine ClinicJ Lukas Laws, Mahsima Shabani, Hollie L Williams, et al.
European Heart Journal|October 30, 2025
Genetic evaluation of early-onset atrial fibrillation: impact on patient managementJ Lukas Laws, Mahsima Shabani, Hollie L Williams, et al.
JACC. Cardiovascular Interventions|November 29, 2023
Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and OutcomesJules Mesnier, Trevor Simard, Richard G Jung, et al.
Journal of the American College of Cardiology|July 23, 2021
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage OcclusionTrevor Simard, Richard G Jung, Kyle Lehenbauer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2024
Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomesSophie Eppinger, Kerstin Piayda, Roberto Galea, et al.
Pageof 15